SlidesetCOVID-19Long COVIDAbstract #1 Deep Multi-Omic Analysis of Colorectal Tissues from People with and Without Long COVID Demonstrates SARS-CoV-2 Persistence and Immune Dysregulation Years after Initial Infection - Brian LaFranchiView Slideset
SlidesetCOVID-19Long COVIDAbstract #2 Persistent Free Spike Antigenemia after SARS-CoV-2 Infection Is Not Associated with the Post-COVID Condition - Lenny CoppensView Slideset
SlidesetCOVID-19Long COVIDAbstract #4 Understanding Long COVID Using Biobank Scale Data - Hanna OllilaView Slideset
SlidesetCOVID-19Long COVIDAbstract #5 Distinct Anti-SARS-CoV-2 Antibody Signatures and Clinical Associations in Adults with Long COVID Compared to Recovered Controls - Rebeca SantanoView Slideset
SlidesetCOVID-19Long COVIDAbstract #6 Alterations in Cortical Gray Matter and Cerebral Blood Flow in Long COVID: A Comparative Neuroimaging Study - Lindsay S. McAlpineView Slideset
SlidesetCOVID-19Long COVIDAbstract #7 Distinct Blood Cytokine Profiles Are Associated with Different Clinical Phenotypes of Post COVID Condition - An HotterbeekxView Slideset
SlidesetCOVID-19Long COVIDAbstract #8 Genome Sequencing Reveals Enrichment of Pathogenic Variants in Genes of Interest in Pediatric Post-Acute COVID-19 Sequelae - Sindhu MohandasView Slideset
SlidesetCOVID-19Long COVIDAbstract #9 Comprehensive T Cell Profiling Reveals CD4⁺ and CD8⁺ T Cell Dysregulation and Adaptive Immune Imbalance in Long COVID - Gemma MoncunillView Slideset
SlidesetCOVID-19Long COVIDAbstract #10 Latent Transition Analysis Shows Improvement of Long COVID Symptoms Over Time: An Analysis of the ORCHESTRA Cohort - Lorenzo CanzianiView Slideset
SlidesetLong COVIDCOVID-19Abstract #11 Analysis Methods for Auxiliary-Variable Dependent Testing in Observational Studies of Long COVID - Tanayott ThaweethaiView Slideset
SlidesetCOVID-19Long COVIDAbstract #12 Joint Modeling of Long-COVID Symptom Surveys in RECOVER - Haojia LiView Slideset
SlidesetCOVID-19Long COVIDAbstract #13 Patterns of Diurnal Cortisol Regulation in Long COVID versus Full Recovery from COVID-19 - Danny Hoi Tsun ChuView Slideset
SlidesetCOVID-19Long COVIDAbstract #15 Quantification of Fibrinaloid Clots in Plasma from Pediatric Long COVID Patients Using a Microfluidic Assay - Kirandeep GillView Slideset
SlidesetCOVID-19Long COVIDAbstract #17 Discovering and Characterizing Phenotypic Presentations in Pediatric Long COVID - Calliope HolingueView Slideset
SlidesetCOVID-19Long COVIDAbstract #19 Patient Perspectives on Long COVID Care Delivery in Primary Care versus Long COVID Specialty Clinics - Tiffany WalkerView Slideset
SlidesetCOVID-19Long COVIDAbstract #21 Social Determinants of Health and Pediatric Long COVID in the United States - Kyung (Kay) RheeView Slideset
SlidesetCOVID-19Long COVIDAbstract #23 A National Structured Care Pathway in the Dutch Post-COVID Academic Centers of Expertise: Systematic Integration of Off-Label Pharmacological Interventions for Dominant Symptoms - Melvin LafeberView Slideset
SlidesetCOVID-19Long COVIDAbstract #24 “Summer Was Happening Somewhere, But I Was Going into Winter”: Conceptualizations of Recovery among People with Persistent COVID-19 Symptoms in a Population-Based Interview Study - Viveka GuzmanView Slideset
SlidesetCOVID-19Long COVIDAbstract #25 STIMULATE-ICP: A Pragmatic, Multi-Centre, Cluster Randomised Trial of an Integrated Care Pathway in Individuals with Long COVID - Melissa HeightmanView Slideset
SlidesetCOVID-19Long COVIDAbstract #26 A Primary Care-Integrated Long COVID Clinical Care Model - Jacqueline BeckerView Slideset
SlidesetCOVID-19Long COVIDAbstract #27 A Novel and Scalable Model of Care Providing Long COVID Treatment Across Australia - Emma TippettView Slideset
SlidesetCOVID-19Long COVIDAbstract #14 A Candidate Biomarker for Non-Restorative, Unrefreshing Sleep in Long COVID - Janet MullingtonView Slideset
SlidesetCOVID-19Long COVIDAbstract #20 Coordination and Curation of Long COVID Resources by Multidisciplinary Long COVID Expert Panel to Improve Long COVID Education and Care - Rasika KarnikView Slideset
SlidesetCOVID-19Long COVIDAbstract #28 SARS-CoV-2 Mpro Protease as a Biomarker and Therapeutic Target in Long COVID: A Real-World Prospective Cohort Study - Johan van WeyenberghView Slideset
SlidesetCOVID-19Long COVIDAbstract #29 Long COVID and Sleep in the Youngest Children: Evidence From the RECOVER-Pediatrics Study - Rakesh BhattacharjeeView Slideset
SlidesetLong COVIDCOVID-19Abstract #30 Preventive Effect of Vaccination on Long COVID in Adolescents with SARS-CoV-2 Infection: RECOVER Pediatric Cohort - Melissa StockwellView Slideset
SlidesetCOVID-19Long COVIDAbstract #31 Low Dose Naltrexone Therapy in Long COVID: Real-World Clinical Experience from a Large Long COVID Clinic - Emma TippettView Slideset
SlidesetLong COVIDCOVID-19Abstract #33 SARS-CoV-2-Specific Monoclonal Antibody Therapy May Be More Beneficial in People with Low Baseline Antibody Titers - Amelia DeitchmanView Slideset
SlidesetCOVID-19Long COVIDAbstract #32 Intrauterine Exposure to SARS-CoV-2 and Infant Neurodevelopment through 18 Months of Age: Findings from the RECOVER Pregnancy Study - Harrison ReederView Slideset
SlidesetCOVID-19Long COVIDAbstract #34 Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial - Carolyn BramanteView Slideset
SlidesetCOVID-19Long COVIDAbstract #35 Rivaroxaban, Colchicine and Famotidine-Loratadine with Specialist Clinical Care for Long COVID, A Multi-Site, Open-Label Randomised Controlled Trial - Emma WallView Slideset
SlidesetCOVID-19Long COVIDAbstract #36 A Randomized Controlled Trial of Nicotinamide Riboside in Individuals with Long-COVID - Edmarie Guzman-VelezView Slideset
SlidesetCOVID-19Long COVIDAbstract #37 Efficacy of Ibudilast for the Treatment of Post COVID-19 Condition – The RECLAIM (REcovering from COVID19 Lingering Symptoms Adaptive Integrative Medicine (RECLAIM)) Platform Trial (RECLAIM-IBU) - Angela CheungView Slideset
